VNRX
Volitionrx Ltd
NYSE MKT: VNRX · HEALTHCARE · MEDICAL DEVICES
$2.62
-0.76% today
Updated 2026-04-30
Market cap
$20.92M
P/E ratio
—
P/S ratio
12.11x
EPS (TTM)
$-4.40
Dividend yield
—
52W range
$2 – $19
Volume
13.3M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
8.0
Growth
A5.0
Quality
C+2.5
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$33.33
+1172.14%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 133.20% QoQ
Risks
- Thin margins at 0.00%
- Negative free cash flow $-5.50M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $306392.00 | $775302.00 | $1.23M | $1.73M | $1.73M |
| Net income | $-30.27M | $-35.32M | $-26.97M | $-23.36M | $-6.27M |
| EPS | — | — | — | — | $-4.40 |
| Free cash flow | $-16.85M | $-19.15M | $-26.47M | $-19.77M | $-5.50M |
| Profit margin | -9,879.11% | -4,555.53% | -2,186.27% | -1,352.16% | — |
Peer comparison
Smart narrative
Volitionrx Ltd trades at $2.62. Our Smart Value Score of 24/100 indicates the stock is weak. TTM revenue stands at $1.73M.
Frequently asked questions
What is Volitionrx Ltd's stock price?
Volitionrx Ltd (VNRX) trades at $2.62.
Is Volitionrx Ltd overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Volitionrx Ltd (VNRX)?
The analyst target price is $33.33, representing +1172.1% upside from the current price of $2.62.
What is Volitionrx Ltd's revenue?
TTM revenue is $1.73M.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio12.11x
ROE-730.00%
Beta1.33
50D MA$3.71
200D MA$7.84
Shares out0.01B
Float0.01B
Short ratio—
Avg volume13.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—